» Articles » PMID: 35992914

Identification and Characterization of N6-methyladenosine Circular RNAs in the Spinal Cord of Morphine-tolerant Rats

Overview
Journal Front Neurosci
Date 2022 Aug 22
PMID 35992914
Authors
Affiliations
Soon will be listed here.
Abstract

Morphine tolerance (MT) is a tricky problem, the mechanism of it is currently unknown. Circular RNAs (circRNAs) serve significant functions in the biological processes (BPs) of the central nervous system. N6-methyladenosine (mA), as a key post-transcriptional modification of RNA, can regulate the metabolism and functions of circRNAs. Here we explore the patterns of mA-methylation of circRNAs in the spinal cord of morphine-tolerant rats. In brief, we constructed a morphine-tolerant rat model, performed mA epitranscriptomic microarray using RNA samples collected from the spinal cords of morphine-tolerant rats and normal saline rats, and implemented the bioinformatics analysis. In the spinal cord of morphine-tolerant rats, 120 circRNAs with different mA modifications were identified, 54 of which were hypermethylated and 66 of which were hypomethylated. Functional analysis of these mA circRNAs found some important pathways involved in the pathogenesis of MT, such as the calcium signaling pathway. In the mA circRNA-miRNA networks, several critical miRNAs that participated in the occurrence and development of MT were discovered to bind to these mA circRNAs, such as miR-873a-5p, miR-103-1-5p, miR-107-5p. MA modification of circRNAs may be involved in the pathogenesis of MT. These findings may lead to new insights into the epigenetic etiology and pathology of MT.

Citing Articles

tRNA epitranscriptomic alterations associated with opioid-induced reward-seeking and long-term opioid withdrawal in male mice.

Blaze J, Browne C, Futamura R, Javidfar B, Zachariou V, Nestler E Neuropsychopharmacology. 2024; 49(8):1276-1284.

PMID: 38332016 PMC: 11224224. DOI: 10.1038/s41386-024-01813-6.


Orbitofrontal intronic circular RNA from Nrxn3 mediates reward learning and motivation for reward.

Dabrowski K, Floris G, Gillespie A, Daws S Prog Neurobiol. 2023; 232:102546.

PMID: 38036039 PMC: 10843848. DOI: 10.1016/j.pneurobio.2023.102546.


Circular RNA regulation and function in drug seeking phenotypes.

Daws S, Gillespie A Mol Cell Neurosci. 2023; 125:103841.

PMID: 36935046 PMC: 10247439. DOI: 10.1016/j.mcn.2023.103841.


mA modifications of circular RNAs in ischemia-induced retinal neovascularization.

Zhou Y, Li B, Wang Z, Tan W, Zou J, Zhou H Int J Med Sci. 2023; 20(2):254-261.

PMID: 36794165 PMC: 9925993. DOI: 10.7150/ijms.79409.


Noncoding RNAs: Novel Targets for Opioid Tolerance.

Deng M, Zou W Curr Neuropharmacol. 2022; 21(5):1202-1213.

PMID: 36453497 PMC: 10286586. DOI: 10.2174/1570159X21666221129122932.

References
1.
Paul A, Smith C, Rahmatullah M, Nissapatorn V, Wilairatana P, Spetea M . Opioid Analgesia and Opioid-Induced Adverse Effects: A Review. Pharmaceuticals (Basel). 2021; 14(11). PMC: 8620360. DOI: 10.3390/ph14111091. View

2.
Gilbert W, Bell T, Schaening C . Messenger RNA modifications: Form, distribution, and function. Science. 2016; 352(6292):1408-12. PMC: 5094196. DOI: 10.1126/science.aad8711. View

3.
Wang X, Ma R, Zhang X, Cui L, Ding Y, Shi W . Crosstalk between N6-methyladenosine modification and circular RNAs: current understanding and future directions. Mol Cancer. 2021; 20(1):121. PMC: 8461955. DOI: 10.1186/s12943-021-01415-6. View

4.
Yue Y, Liu J, He C . RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev. 2015; 29(13):1343-55. PMC: 4511210. DOI: 10.1101/gad.262766.115. View

5.
Rybak-Wolf A, Stottmeister C, Glazar P, Jens M, Pino N, Giusti S . Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed. Mol Cell. 2015; 58(5):870-85. DOI: 10.1016/j.molcel.2015.03.027. View